Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Advances in soft tissue sarcoma from ESMO 2012

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.10.12
Views: 5149

Prof Jean Yves Blay - Université Claude Bernard, France

Professor Jean Yves Blay from Université Claude Bernard, France, talks to ecancer TV about recent advances in soft tissue sarcoma.


Professor Blay first outlines current treatment strategies for soft tissue sarcoma at the various stages of the disease.  He reviews new study results with doxorubicin, and discusses whether doxorubicin should be used as a single or combination therapy.  He also shares his views on the potential for trabectedin, and the future direction of clinical studies in this endogenous tumour with many now-recognised sub-types.


Professor Blay reviews the main questions that need to be answered in soft tissue sarcomas, including identifying the first molecular event using the latest technology in genomic analysis.  Finally, Professor Blay shares his views on the future of both targeted and cytotoxic therapies in soft tissue sarcoma.


This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).


Sarcomas ESMO 2012

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation